CATX Perspective Therapeutics Inc

$CATX buyout could come at anytime especially with manufacturing nation wide in place with excess capacity STRONG BUYOUT 💰💰💰🚀🚀🚀🚀🚀🚀🥂🥂🥂

$CATX Whatever is going on it doesnt matter. Oct 19 and 23, will establish the direction of our investment. Perspective will present updated VMT-α-NET data covering Cohorts 1–3, including safety and efficacy results in advanced SSTR2+ neuroendocrine tumors. The rapid oral presentation is scheduled for 4:25–4:30 p.m. Madrid time, which is 10:25–10:30 a.m. Eastern / 7:25–7:30 a.m. Pacific. Importantly, ESMO is expected to release the abstract details on October 19, so we may get meaningful data four days before the actual presentation.

$CATX Great data ensues. Otherwise wouldn’t have been 11 million covering. Those shorts must have had 1-on-1’s at Morgan Stanley and Oppenheimer last week. Writing on wall $237 million cash, great data and $109 million in world class manufacturing facilities with a ton of un monetized capacity. Plus lots of outlicensing inbound calls.

$CATX I’m issuing a buy rating with a price target of 18$. This stock hasn’t moved in years and the company has grown is now gonna be starting phase 3 of pb-212. The value of this company is not reflected by its share price! What a great time to buy!

$CATX Lantheus-selling hypothesis is now confirmed. A Schedule 13D/A accepted by the SEC at 4:19 p.m. ET Wednesday shows that Lantheus continued selling aggressively through September 22: * September 18: 750,000 shares at an average $2.85 * September 21: 215,974 shares at $2.9645 * September 22: 1,396,987 shares at $2.8976 The question is, will they go to zero? And the second question is why would they sell if CATX is very high potential and they obviously have insider Insight. The answer I believe is simple… As we all know, they are being purchased by Curium. The $8 billion deal pales in comparison to the $30 million of stock involved in the sale of CATX holdings. The sale is for housekeeping. The sale is NOT due to their insider knowledge… The dumping of stock because of insider knowledge would never be allowed by their lawyers… It is plausible that it’s an irrelevant $30 million holding if CURIUM plans on buying CATX anyway

$CATX omg just blow pass 3 already and stay there. This is like watching “to be continued” episodes where nothing is happening

$CATX we are at 1.6 million so far. Lets see what the last 1/2 hour gets us. Insay over 2.5 million and a ckose over 3

$CATX Somebody knows something otherwise there wouldn’t have been 7 million share buying at close on Friday

$CATX I may be wrong, but I’m putting my money on Lantheus selling to zero which is about another 8-ish million shares… Figure that would take about 2-3 weeks depending on liquidity I don’t think they really care about impacting the stock price… But it will have it drop some amount. I’m gonna keep my powder dry and try to keep checking. We lose visibility once they go below 5ish million shares which is about 3 million from where they are today. that’s the 5% mark

$CATX Has 129,000 sq feet of facilities across USA that alone could produce $150 million in cdmo revenues in radiopharmaceuticals

$CATX Wow, I should have waited to buy more. I didn't think the SP would go this low again, with the current news and the upcoming October updates. You can't time or try to understand the market ups/downs..it's lije golf and life.

$CATX going to FDA and the ability to service the PB-212 pretty much 85% of the country because you own everything from raw material to finished product available to the 85%. Immediately? Do you really think that this hasn’t been thought through and a Big fish is already in place when that happens?  Either way..CATX eliminating any risk for themselves or to the Big fish..

$CATX We’ll have 3 to 5 locations to sell along with the entire chain 1st to FDA approval for PB-212 in tow..like I said..I think the analyst have us woefully underpriced for the long haul.. and what I believe this company is worth.

$CATX I guess the question is, at what price does someone buy the whole Lantheus stake? A lot of big investors from $3.79 that could DCA now…

$CATX I loaded more last week, and it's been going ⬇️. I've been in since Isoray, so I'm afraid to buy anymore..I keep losing.

$CATX I went over all the public documents and there is no threshold of margin concern - not for such a small pittance of an investment… they would not settle down to the current level just for cushion… 9.5% would’ve solve to that And I looked at all of the other holdings they are only selling CATX… It is pretty clear to me that lantheus it’s gonna either sell to a 5% position or a 0%. Also they are not optimizing their sales price. They are selling into existing liquidation like the volume created by the index removal. They are clearly selling to reduce their holding not for profit… Therefore, why are they selling Is the big question. I’d love to think it has something to do with the potential M&A activity… and I don’t think it’s because of their inside knowledge of October… That would be suicide from a legal perspective.

$CATX have to assume Lantheus is selling out that being said, we have 8 million to get through. This is not going to help short term

$CATX how is this not up more on this news? We already know VMTaNet is better performing than current treatments…Merck just confirmed that PSV must be working…2 assets, for the price of nothing at these prices…

$CATX Looks like State Street added an additional 2.9 million shares bringing their total number of shares to just over 6 million according to their latest filing on fintel.io.

$CATX Sanofi deprioritized and discontinued its involvement with AlphaMedix (SAR447873) in early 2026 due to concerns over long-term toxicities like renal insufficiency and dysphagia (difficulty swallowing). This decision was made despite the drug demonstrating a highly impressive 60% investigator-assessed objective response rate (ORR) in PRRT-naïve gastroenteropancreatic neuroendocrine tumor (GEP-NET) patients at the ESMO 2025 Congress. So, competition was destroying kidneys.